Serotonergic Dissection of Obsessive Compulsive Symptoms: A Challenge Study with m-Chlorophenylpiperazine and Sumatriptan
The DOI matches its Crossref record.
Abstract
We have conducted a pharmacological challenge experiment in 10 medication-free obsessive compulsive (OC) disorder (OCD) patients. We used a placebo-controlled paradigm for m-chlorophenylpiperazine (mCPP) and sumatriptan challenges. Endocrine, physiological and behavioral variables were assessed at baseline and over a 3-hour period after the challenge. Both cortisol and prolactin were significantly elevated in OCD patients following mCPP administration. Both mCPP and sumatriptan caused significant OC symptom exacerbation with the response to sumatriptan being more robust. We conclude that the 5-HT 1Dβ receptor may play a role in the pathophysiology of OCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pittenger, C., Bloch, M. H., & Williams, K. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.006 · Cited by 426
“Agonists of the serotonin 1B and 1D receptors have been found to exacerbate OCD symptoms (Koran et al., 2001; Gross-Isseroff et al., 2004; Zohar et al., 2004).”
BackgroundNeurobiology of Obsessive-Compulsive Disorder:Serotonin and Beyond
Westenberg, H. G. M., Fineberg, N. A., & Denys, D. (2007) · CNS Spectrums · doi:10.1017/s1092852900002479 · Cited by 148
Shanahan, N. A., Holick Pierz, K. A., Masten, V. L., Waeber, C., Ansorge, M., Gingrich, J. A., Geyer, M. A., Hen, R., & Dulawa, S. C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.026 · Cited by 102
“8-OH-DPAT increased PPI at the 6 and 12dB prepulse intensities in 5-HTTWT and -HT mice, but had no effect in -KO mice, as indicated by a treatment x pretreatment x prepulse intensity interaction (F(4,62)=3.”
BackgroundMethodInfluentialAhmari, S. E., & Rauch, S. L. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01130-2 · Cited by 95
The current status of association studies in obsessive-compulsive disorder
Hemmings, S. M. J., & Stein, D. J. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.02.011 · Cited by 83
Shanahan, N. A., Velez, L. P., Masten, V. L., & Dulawa, S. C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.032 · Cited by 72
Assessing the validity of current mouse genetic models of obsessive-compulsive disorder
Wang, L., Simpson, H. B., & Dulawa, S. C. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832a80ad · Cited by 50
“Many (Zohar et al., 1987; Hollander et al., 1992; Erzegovesi et al., 2001; Gross-Isseroff et al., 2004) but not all human pharmacological challenge studies have shown that the 5-HT2B/C agonist 1-(3-chlorophenyl)piperazine (m-CPP) exacerbates symptoms in OCD patients (McDougle et al., 1995; Khanna…”
BackgroundA closer look to neural pathways and psychopharmacology of obsessive compulsive disorder
Gargano, S. P., Santos, M. G., Taylor, S. M., & Pastis, I. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1282246 · Cited by 18
Metadata
- Authors
- Gross-Isseroff, R., Cohen, R., Sasson, Y., Voet, H., & Zohar, J.
- Venue
- Neuropsychobiology
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 50
- Issue
- 3
- Pages
- 200-205
- ISSN
- 0302-282X (ISSN-L)
- 1423-0224
- OpenAlex
- W2055670384
- Cited by
- 86
- References
- 0
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.